Picture supply: Getty Pictures
Aviva’s (LSE: AV) share worth nonetheless suffers from the lengthy shadow of its previous, in my opinion. The market costs the agency as if it had been nonetheless the messy, sprawling, dividend‑slicing insurer buyers keep in mind.
However the Aviva of 2026 is a really completely different operation: capital‑mild, money‑wealthy, tightly centered and constantly delivering on its monetary targets forward of schedule.
That disconnect is exactly this misalignment that creates such a compelling undervaluation alternative for savvy lengthy‑time period buyers.
Undervalued to friends?
A very good start line to evaluate whether or not a inventory is undervalued is evaluating it on key measures with its opponents. I exploit forward-looking measures as a result of I’m inquisitive about a agency’s future earnings energy, not what it has achieved previously.
On the important thing price-to-sales measure, Aviva’s 0.5 is backside of its peer group, which averages 2.1. The corporations comprise Authorized & Normal at 1.3, Admiral at 1.7, Swiss Life at 2.6, and Prudential at 3.1. So, it seems very undervalued on this foundation.
The identical is true of its 12.6 price-to-earnings ratio towards the 12.9 common of its opponents. And it additionally seems low cost on its 1.8 price-to-book ratio versus its friends’ common of 4.
Really undervalued?
A reduced money move evaluation pinpoints the place any inventory ought to be priced — its ‘fair value’ — based mostly on the underlying enterprise’s fundamentals. It does this by projecting a agency’s future money flows after which discounting them again to right now. Some analysts’ modelling is extra bearish than mine although.
Nevertheless, based mostly alone DCF assumptions — together with a 7.2% low cost charge — Aviva shares are 51% undervalued at their present £6.09 worth. This suggests a good worth for the shares of round £12.43 — greater than double the place it trades right now.
Share costs can converge to their honest worth over time. So this price-value hole suggests a probably very good shopping for alternative to think about right now if these DCF assumptions maintain.
Supported by sturdy earnings progress?
Revenue progress finally powers any inventory worth increased over time. A threat right here for Aviva is {that a} sharp fall in monetary markets may scale back the worth of its funding portfolio and weaken its capital place. One other is that extended excessive inflation may enhance its working prices and scale back the profitability of its core insurance coverage and financial savings companies.
Nevertheless, analysts forecast that Aviva’s earnings progress will common a robust 15% a 12 months to end-2028. This seems conservative to me, given the agency’s excellent 2025 outcomes, launched on 5 March.
These confirmed working revenue hovering 25% 12 months on 12 months to £2.2bn, attaining the £2bn+ goal one 12 months early. In the meantime, working earnings per share jumped 17% to 56p. Given these glorious figures, administration introduced a £350m buyback, which tends to assist share worth positive aspects.
My funding view
I imagine Aviva is a basically a lot stronger enterprise than its valuation implies. The transformation of the group is evident in each its monetary supply and its ahead earnings energy. But the market continues to cost it as if little has modified.
For lengthy‑time period buyers in search of main capital appreciation potential, I believe that disconnect may very well be extremely engaging. And I’ll actually be including to my present £20,000 holding very shortly.
Within the meantime, different high-yielding, undervalued FTSE shares have additionally caught my eye.
